MySmarTrend
← Insider Monitor
Aardvark Therapeutics, Inc. logo
AARD

Aardvark Therapeutics, Inc.

Nasdaq · Pharmaceutical Preparations

2
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs that target the body's neural gut-brain signaling pathways to treat hyperphagia and metabolic diseases, including rare genetic obesity disorders such as Prader-Willi syndrome.

Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Sun NelsonSee RemarksSell$321KSep 11, 2026
Sun NelsonSee RemarksSell$74KSep 10, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for AARD.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable AARD activity by email

Free alerts for the insider and congressional trades worth watching.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.